HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Enhanced tumor immunogenicity through coupling cytokine expression with antigen presentation.

Abstract
The density of tumor antigen in conjunction with major histocompatibility complex (MHC) class I molecules on the cell surface affects cytotoxic T cell (CTL) function in an active antitumor immune response. Thus, methods to enhance antigen expression/presentation could augment the effect of cancer immune therapy. In the present study, we investigated the feasibility of modifying a cytokine signal peptide with a tumor antigenic epitope. We inserted the genes encoding the MHC class I-restricted antigenic epitope of chicken ovalbumin and tyrosinase-related protein 2 into the signal sequence of the interleukin-2 gene, replacing part of the signal sequence at different positions. Our results showed that these modified signal peptides still functioned, as indicated by cytokine secretion. The antigenic epitope within the modified signal peptide could be processed properly and presented on tumor cell surface. Tumor cells demonstrated enhanced immunogenicity as indicated by increased susceptibility to CTL lysis in vitro and decreased tumor grow in vivo after gene modification. These data provide potential perspectives in designing therapeutic or vaccine strategies in immuno-gene therapy of cancer.
AuthorsXianghui He, Tom C Tsang, Phoebe Luo, Tong Zhang, David T Harris
JournalCancer gene therapy (Cancer Gene Ther) Vol. 10 Issue 9 Pg. 669-77 (Sep 2003) ISSN: 0929-1903 [Print] England
PMID12944986 (Publication Type: Journal Article)
Chemical References
  • Antigens, Neoplasm
  • Cytokines
  • Epitopes
  • Histocompatibility Antigens Class I
  • Interleukin-2
  • Protein Sorting Signals
  • Interferon-gamma
Topics
  • Amino Acid Sequence
  • Animals
  • Antigen Presentation
  • Antigens, Neoplasm (genetics, immunology)
  • Base Sequence
  • Cell Division
  • Cell Line, Tumor
  • Cytokines (genetics, immunology, metabolism, therapeutic use)
  • Epitopes (genetics, immunology)
  • Genetic Therapy
  • Histocompatibility Antigens Class I (immunology)
  • Immunotherapy
  • Interferon-gamma (genetics, immunology, metabolism)
  • Interleukin-2 (genetics, immunology, metabolism, therapeutic use)
  • Mice
  • Mice, Transgenic
  • Molecular Sequence Data
  • Neoplasm Invasiveness
  • Neoplasm Transplantation
  • Neoplasms (genetics, immunology, metabolism, pathology)
  • Protein Sorting Signals (genetics, physiology)
  • Sequence Alignment
  • T-Lymphocytes, Cytotoxic (cytology, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: